The regulator of G protein signaling (RGS) domain of G protein-coupled receptor kinase 5 (GRK5) regulates plasma membrane localization and function. by Xu, Hua et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Biochemistry and Molecular Biology
Faculty Papers Department of Biochemistry and Molecular Biology
7-1-2014
The regulator of G protein signaling (RGS) domain
of G protein-coupled receptor kinase 5 (GRK5)
regulates plasma membrane localization and
function.
Hua Xu
Department of Biochemistry and Molecular Biology, Thomas Jefferson University
Xiaoshan Jiang
Department of Biochemistry and Molecular Biology, Thomas Jefferson University; Center for Science Research, Guilin Medical
University
Ke Shen
Center for Science Research, Guilin Medical University
Christopher C. Fischer
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Christopher.Fischer@jefferson.edu
Philip B Wedegaertner
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philip.Wedegaertner@jefferson.eduLet us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/bmpfp
Part of the Medical Molecular Biology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Biochemistry and Molecular Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Xu, Hua; Jiang, Xiaoshan; Shen, Ke; Fischer, Christopher C.; and Wedegaertner, Philip B, "The
regulator of G protein signaling (RGS) domain of G protein-coupled receptor kinase 5 (GRK5)
regulates plasma membrane localization and function." (2014). Department of Biochemistry and
Molecular Biology Faculty Papers. Paper 80.
http://jdc.jefferson.edu/bmpfp/80
Volume 25 July 1, 2014 2105 
MBoC | ARTICLE
The regulator of G protein signaling (RGS) 
domain of G protein–coupled receptor kinase 5 
(GRK5) regulates plasma membrane localization 
and function
Hua Xua,*, Xiaoshan Jianga,b,*, Ke Shenb, Christopher C. Fischera, and Philip B. Wedegaertnera
aDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107; bCenter for 
Science Research, Guilin Medical University, Guilin, Guangxi 541004, China
ABSTRACT The G protein–coupled receptor (GPCR) kinases (GRKs) phosphorylate activated 
GPCRs at the plasma membrane (PM). Here GRK5/GRK4 chimeras and point mutations in 
GRK5 identify a short sequence within the regulator of G protein signaling (RGS) domain in 
GRK5 that is critical for GRK5 PM localization. This region of the RGS domain of GRK5 coin-
cides with a region of GRK6 and GRK1 shown to form a hydrophobic dimeric interface (HDI) 
in crystal structures. Coimmunoprecipitation (coIP) and acceptor photobleaching fluorescence 
resonance energy transfer assays show that expressed GRK5 self-associates in cells, whereas 
GRK5-M165E/F166E (GRK5-EE), containing hydrophilic mutations in the HDI region of the 
RGS domain, displays greatly decreased coIP interactions. Both forcing dimerization of GRK5-
EE, via fusion to leucine zipper motifs, and appending an extra C-terminal membrane-binding 
region to GRK5-EE (GRK5-EE-CT) recover PM localization. In addition, GRK5-EE displays a 
decreased ability to inhibit PAR1-induced calcium release compared with GRK5 wild type 
(wt). In contrast, PM-localized GRK5-EE-CaaX (appending a C-terminal prenylation and poly-
basic motif from K-ras) or GRK5-EE-CT shows comparable ability to GRK5 wt to inhibit PAR1-
induced calcium release. The results suggest a novel model in which GRK5 dimerization is 
important for its plasma membrane localization and function.
INTRODUCTION
The G protein–coupled receptor (GPCR) kinases (GRKs) specifically 
phosphorylate agonist-activated GPCRs at the cytoplasmic surface 
of the plasma membrane (PM). Phosphorylated GPCRs uncouple 
the heterotrimeric G proteins and recruit arrestins to form receptor/
arrestin complexes that undergo endocytosis, resulting in GPCR 
degradation or recycling back to the PM. GRK-regulated desensiti-
zation of GPCR signaling can thus prevent an excessive cellular re-
sponse to receptor activation and provides a necessary turn-off 
mechanism to regulate GPCR signaling in response to variable 
stimuli.
Seven GRK family members can be divided into three subgroups 
based on their amino acid identity: GRK1 and 7; GRK2 and 3; and 
GRK4–6. GRK1 and 7 are specifically expressed in the retina. The 
other GRKs are ubiquitously expressed, except for GRK4, which is 
mostly restricted to testes, brain, and kidney. All GRKs share similar 
architecture. After a short N-terminal region, GRKs have a regulator 
of G protein signaling (RGS) domain, a catalytic kinase domain, and 
a variable C-terminal region (Gurevich et al., 2012).
To phosphorylate activated GPCRs in a timely manner, GRKs 
need to localize to the cytoplasmic surface of the PM. The mecha-
nisms used by GRKs to bind membranes remain to be fully eluci-
dated, but it is clear that GRK C-termini play prominent roles. Of 
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required (Stoffel et al., 1994, 1998; Loudon and Benovic, 1997; 
Pronin et al., 1998; Thiyagarajan et al., 2004; Vatter et al., 2005; 
Jiang et al., 2007). Although not yet tested for subcellular localiza-
tion, the C-terminus of GRK4α (hereafter referred to as GRK4) like-
wise contains a predicted amphipathic helix and sites for palmitoyla-
tion (Premont et al., 1996; Pronin et al., 1998; Thiyagarajan et al., 
2004). However, when stably expressed in human embryonic kidney 
(HEK293) cells, immunofluorescence microscopy demonstrated that 
GRK4 was distributed throughout the cytoplasm, in contrast to the 
strong PM localization of GRK5 and 6 (Figure 1A). Consistent with 
the immunofluorescence analysis, separation of cell lysates by high-
speed centrifugation into soluble/cytosol (S) or particulate/mem-
brane (P) fractions revealed that GRK4 was found almost exclusively 
in the soluble fraction, whereas GRK5 and 6 were predominantly 
found in the particulate fraction (Figure 1B). These results indicate 
an unexpected difference in subcellular localization among the 
members of this subfamily of GRKs.
To identify the basis for this difference, we focused on a compari-
son of PM-localized GRK5 and cytoplasmic GRK4, and we first 
tested whether differences in their C-termini could explain the dra-
matic difference in subcellular localization. GRK5 remains at the PM 
when its C-terminus is replaced by that of GRK4 (Figure 2), indicat-
ing that the C-terminus of GRK4 has sufficient PM targeting informa-
tion to compensate for the loss of GRK5’s C-terminus. Moreover, 
GRK4 remains in the cytoplasm when its C-terminus is replaced by 
that of GRK5 (Figure 2); thus, although the C-terminus of GRK5 is 
required for GRK5 PM localization, it is not sufficient to promote PM 
localization of GRK4. Taken together, these results show that C-ter-
minal differences are not responsible for the different subcellular 
localization of GRK5 and 4 and suggest that protein regions in addi-
tion to the C-terminus play a critical role in regulating PM localiza-
tion of this GRK family.
Therefore we reasoned that additional GRK5/4 chimeras would 
identify novel determinants of PM localization (Figure 2A). We 
focused on the RGS domains because they contained the least 
sequence identity in GRK5 versus GRK4. Replacing amino acids 
95–134 in the RGS domain of GRK5 with amino acids 95–134 of 
GRK4 did not affect localization; this GRK5/4RGS(95–134) chimera 
remained localized at the PM similar to wt GRK5 (Figure 2). On the 
other hand, a GRK5/4RGS(135–170) chimera, in which amino acids 
135–169 of GRK5 were replaced with amino acids 135–170 of GRK4, 
was localized in the cytoplasm (Figure 2). Thus a critical and novel 
determinant for membrane localization of GRK5 appears to be con-
tained within amino acids 135–169 of its RGS domain. Further mu-
tagenesis showed that chimera GRK5/4RGS(165–169), which simply 
interest, the C-terminal regions of the different GRK subfamilies are 
quite diverse in terms of sequence and structure and indeed have 
been shown to use unique mechanisms to promote GRK PM local-
ization (Gurevich et al., 2012). GRK1 and 7 rely on a carboxyl-termi-
nal CaaX motif that promotes covalent modification by a farnesyl or 
geranylgeranyl isoprenoid (Inglese et al., 1992); these hydrophobic 
lipids are well known to serve as membrane anchors. In contrast, 
GRK2 and 3 each contains a pleckstrin homology (PH) domain in the 
C-terminal region that mediates translocation of the kinases from 
the cytoplasm to the PM upon GPCR activation (Pitcher et al., 1992; 
Barak et al., 1999; Carman et al., 2000). The PH domain allows GRK2 
and 3 to anchor on the PM by interacting with both phospholipids 
and free G protein βγ subunits. Finally, GRK4–6 all have a predicted 
C-terminal amphipathic helix motif defined by a hydrophobic helix 
core surrounded by several basic residues (Pronin et al., 1998; 
Thiyagarajan et al., 2004; Jiang et al., 2007). GRK5 and 6 appear to 
localize constitutively at the PM in cells, but subcelluar localization 
of GRK4 has not been well addressed. In addition to the amphip-
athic helix, GRK4 and 6 can be palmitoylated on C-terminal cysteines 
(Stoffel et al., 1994; Premont et al., 1996; Loudon and Benovic, 
1997; Vatter et al., 2005; Jiang et al., 2007). The covalent attach-
ment of palmitate appears to be necessary, together with the 
amphipathic helix, for PM localization of GRK6 (Jiang et al., 2007), 
but the role of the amphipathic helix and palmitoylation in GRK4 
remains to be examined.
To identify additional mechanisms that regulate PM localization 
of GRK5, we compared the localization of GRK4–6 and then focused 
on GRK5 in these studies. Surprisingly, whereas expressed GRK5 
and 6 are localized on the PM, expressed GRK4 is found predomi-
nantly in the cytoplasm. Using GRK5/4 chimeras and point muta-
tions in GRK5, we identify amino acids in the RGS domain of GRK5 
that are necessary for PM localization. These amino acids map to a 
region in GRK6 and 1 determined in crystal structures to mediate a 
hydrophobic dimeric interface (HDI), and, consequently, we show 
that expressed GRK5 can exist in a complex in cells. This study sug-
gests a novel mechanism in which amino acids in the RGS domain of 
GRK5 regulate its PM localization by mediating a dimeric 
interaction.
RESULTS
GRK5/4 chimeras reveal a novel protein region involved 
in PM localization of GRK5
Previous work demonstrated the importance of an amphipathic he-
lix in the C-terminal extension of GRK5 and 6 for PM localization, 
and for GRK6, palmitoylation in the C-terminal extension is also 
FIGURE 1: Subcellular localization of GRK4–6. (A) HEK293 cells stably expressing GRK4, 5 or 6, as indicated, were 
subjected to immunofluorescence staining using a GRK4–6 antibody that detects all three GRKs. Bar, 10 μm. (B) HEK293 
cells stably expressing GRK4, 5, or 6 were lysed, and the cell lysates were fractionated by high-speed centrifugation into 
soluble (S) and particulate (P) fractions, as described in Materials and Methods. GRKs were detected by immunoblotting 
with a GRK4–6 antibody. The black bar indicates a 70-kDa standard. Images and immunoblots shown are representative 
from at least three experiments.
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replaces four GRK5 amino acids within 165–169 with their GRK4 
amino acid counterparts (M165S/F166Y/D168S/R169Q), was suffi-
cient to shift localization of GRK5 into the cytoplasm and soluble 
fraction (Figure 2).
A novel determinant of PM localization of GRK5 maps 
to a hydrophobic dimeric interface
Strikingly, the region of the RGS domain identified in the foregoing 
contains part of a conserved HDI identified in crystal structures of 
GRK6 and 1 (Lodowski et al., 2006; Singh et al., 2008; Boguth et al., 
2010; Tesmer et al., 2012). The HDI in the crystal structure of GRK6 
is composed of key hydrophobic residues I39, I165, Y166, and F527. 
In GRK5, amino acids at the corresponding positions are I39, M165, 
F166, and F527; the similarity of these key residues in GRK5 and 
6 suggests that GRK5 would also contain an HDI (Figure 3A and 
Supplemental Figure S1). Note that M165 and F166 are found 
within the RGS domain region identified in Figure 2 as being critical 
for PM localization of GRK5; in the GRK5/4RGS(135–170) and 
GRK5/4RGS(165–169) chimeras, which show loss of PM localization, 
M165 is replaced with a serine, along with other amino acid 
substitutions.
To test more directly whether the HDI region of the RGS domain 
plays a role in regulating GRK5 PM localization, we mutated three 
key HDI-forming hydrophobic residues, M165, F166, and F527, to 
negatively charged D or E in order to disrupt the ability of these side 
chain to mediate hydrophobic interactions. Similar mutations to 
negatively charged amino acids were shown to not affect the kinase 
activity of GRK6 (Lodowski et al., 2006). Single mutants M165E, 
F166E, and F527D and double mutants M165E/F166E (EE) and 
M165E/F527D (ED) were expressed in HEK293 cells, and subcellular 
localization was assayed by immunofluorescence microscopy and 
subcellular fractionation. Of interest, all mutants showed much re-
duced PM localization compared with wt GRK5 (Figure 3B and 
Supplemental Figure S2); the double mutants displayed prominent 
localization in the cytoplasm, whereas the single mutants showed 
strong cytoplasmic localization with a retention of some PM staining. 
Fractionation analyses showed a decrease of membrane localization 
for all GRK5 mutants (Figure 3C). Double mutant GRK5-EE showed 
the highest loss of membrane binding; >65% of GRK5-EE was found 
in the soluble fraction (Figure 3C). To examine the possibility that 
the introduction of the negatively charged glutamic acids was pre-
venting PM localization of GRK5 by decreasing binding to nega-
tively charged membrane phospholipids, we generated two addi-
tional mutants. Both the neutral GRK5-M165A/F166A mutant and 
the positive-charge GRK5-M165K/F166K mutant showed loss of PM 
localization and membrane fractionation identical to GRK5-EE 
FIGURE 2: GRK5/4 chimeras identify a region of the RGS domain as a 
novel determinant of PM localization of GRK5. (A) Schematic 
representations of GRK chimeras. In GRK4/5CT(45), the C-terminus of 
GRK4 (amino acids 548–577) is replaced with the C-terminus of GRK5 
(amino acids 546–590). Conversely, in GRK5/4CT(30), the C-terminus 
of GRK5 (amino acids 546–590) is replaced with that of GRK4 (amino 
acids 548–577). Chimera GRK5/4RGS(95–134) was generated by 
replacing a region of the RGS domain (amino acids 95–134) of GRK5 
with the corresponding region of the GRK4 RGS domain (amino acids 
95–134). Chimera GRK5/4RGS(135–170) was generated by replacing a 
second part of the RGS domain (amino acids 135–169) of GRK5 with 
the corresponding region of the GRK4 RGS domain (amino acids 
135–170). Chimera GRK5/4RGS(165–169) was generated by replacing 
amino acids 165–169 of GRK5 with the amino counterparts from 
GRK4, resulting in the four amino substitutions M165S/F166Y/D168S/
R169Q in GRK5. (B) Plasmids expressing the indicated chimeras of 
GRK5 and 4 were transiently transfected into HEK293 cells. 
Immunofluorescence microscopy was performed using the GRK4–6 
antibody as described in Materials and Methods. Images shown are 
representative from at least three experiments. Bar, 10 μm. 
(C) Plasmids expressing the indicated chimeras of GRK5 were 
transiently transfected into HEK293 cells, and subcellular fractionation 
into soluble (S) and particulate (P) fractions was performed, as 
described in Materials and Methods. GRK5 and 4 constructs were 
detected after immunoblotting with a GRK4–6 monoclonal antibody 
or a GRK4 polyclonal antibody, respectively. The black bar indicates a 
70-kDa standard. The graph shows quantitation (average ± SD, n ≥ 3) 
of gel bands of S and P fractions from multiple experiments. Statistical 
analysis was performed using one-way analysis of variance (p < 0.05) 
to indicate significant difference among all the groups, followed by 
t-test comparison between any of the two groups. Asterisks indicate 
statistical significance (p < 0.05) of the indicated S fraction vs. the 
GRK5 S fraction or of the indicated P fraction vs. the GRK5 P fraction.
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(Figure 3, B and C), arguing against a spe-
cific role for the amino acid side chain’s 
charge in disrupting PM localization of 
GRK5. Taken together, these results show 
that disruption of key hydrophobic residues 
in the GRK5 HDI domain significantly im-
paired the PM targeting of GRK5, suggest-
ing that this HDI domain contributes to 
GRK5 PM localization.
HDI-mediated complex formation 
of GRK5 in cells
GRK6 and GRK1 exist as HDI-mediated di-
mers in multiple crystal structures (Lodowski 
et al., 2006; Singh et al., 2008; Boguth 
et al., 2010; Tesmer et al., 2012). Although 
the structure of GRK5 has not been re-
ported, it is predicted, based on sequence 
similarity, to contain a similar HDI domain 
capable of mediating its homodimerization 
(Figure 3A and Supplemental Figure S1). 
However, it was reported that the purified, 
palmitoylation-deficient mutant of GRK6 
was a monomer in solution (Lodowski et al., 
2006), as was a nonfarnesylated, soluble 
form of GRK1 (Singh et al., 2008), and puri-
fied, soluble GRK5 also behaves as a mono-
mer in solution (J. Benovic, personal com-
munication). Nonetheless, the authors 
speculated that GRK6 and 1 may physio-
logically dimerize inside cells in the pres-
ence of membranes and interacting pro-
teins (Lodowski et al., 2006; Singh et al., 
2008; Tesmer et al., 2012). The lack of dimer 
detection of soluble GRK1, 5, or 6 suggests 
that if self-association occurs in cells, it may 
be weak and thus difficult to detect. Keep-
ing this in mind, we sought to examine 
whether GRK5 can form complexes in cells.
First, we examined complex formation 
by coimmunoprecipitation. Because numer-
ous attempts to coimmunoprecipitate differ-
ent tagged forms of GRK5 from cell lysates 
failed to provide reliable results, we used a 
cell-permeable cross-linker to attempt to 
trap GRK5 protein complexes before cell ly-
sis. GRK5 tagged with S and hemagglutinin 
(HA) epitopes, respectively, were expressed 
in HEK293 cells, and, after treatment of the 
cells with the cross-linker dithiobis[succinimi
dylpropionate] (DSP), cell lysates were sub-
jected to an affinity precipitation assay to 
pull down S-tagged GRK5 (GRK5-S) using 
S-protein-agarose. In the precipitate, HA-
tagged GRK5 (GRK5-HA) was detected by 
immunoblotting, suggesting an interaction 
of the two tagged forms of GRK5 (Figure 
4A). Identical pull-down assays with HDI-
disrupted GRK5-EE revealed a lack of GRK5-
EE-S and GRK5-EE-HA coprecipitation, sug-
gesting that GRK5 dimerization is dependent 
on its HDI. To rule out the trivial explanation 
FIGURE 3: A hydrophobic dimeric interface within the RGS domain is a novel determinant for 
GRK5 PM targeting. (A) The region of the RGS domain of GRK5 identified in the 
GRK5/4RGS(135–170) chimera is aligned with the same region of GRK4 and GRK6 (top 
alignment), and a short region at the end of helix 11 of the RGS domains of GRK4–6 is also 
aligned (bottom alignment). Key amino acids that are mutated here in GRK5 and that 
correspond to amino acids that form important hydrophobic interactions in the dimeric structure 
of GRK6 are underlined. (B) Plasmids expressing the following HDI mutants of GRK5 were 
transiently transfected into HEK293 cells: GRK5 (wt), GRK5-M165E (M165E), GRK5-F166E 
(F166E), GRK5-F527D (F527D), GRK5-M165E/F166E (EE), GRK5-M165E/F527D (ED), GRK5-
M165A/F166A (AA), and GRK5-M165K/F166K (KK). Immunofluorescence microscopy was 
performed using the GRK4–6 antibody as described in Materials and Methods. Shown are 
images of one to three cells under a 60× objective. Images shown are representative images 
from at least three experiments. Bar, 10 μm. (C) Plasmids expressing the indicated HDI mutants 
of GRK5 were transiently transfected into HEK293 cells, and subcellular fractionation into 
soluble (S) and particulate (P) fractions was performed, as described in Materials and Methods. 
GRK5 was detected after immunoblotting with a GRK4–6 antibody. The graph shows 
quantitation (average ± SD, n ≥ 3) of gel bands of S and P fractions from multiple experiments. 
Statistical analysis was performed using one way analysis of variance (p < 0.05) to indicate 
significant difference among all the groups, followed by t-test comparison between any of the 
two groups. Asterisks indicate statistical significance (p < 0.05) of the indicated S fraction vs. the 
wt S fraction or of the indicated P fraction vs. the wt P fraction.
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protein αi2 and was coexpressed with GRK5-mCherry (Figure 4B). 
Much-reduced FRET was observed by the acceptor photobleaching 
approach in cells expressing Gαi2-GFP and GRK5-mCherry (Figure 
4, C and D), suggesting that the observed GRK5-GFP/GRK5-
mCherry interaction is not simply due to colocalization at the PM. 
Taken together, the different experimental approaches in Figure 4 
provide evidence for GRK5 self-association in transfected cells.
Forced dimerization of GRK5-EE rescues its impaired 
PM targeting
We showed that disruption of the HDI in GRK5-EE resulted in de-
creased GRK5 complex formation and significant loss of GRK5 PM 
localization (Figures 3 and 4), suggesting a model in which GRK5 
dimerization is critical for its PM localization. Thus we hypothesized 
that inducing dimerization of GRK5-EE would promote relocalization 
of GRK5-EE to the PM. To test this prediction, we appended strongly 
dimerizing leucine zipper motifs derived from the transcription fac-
tors Jun (JLZ) and Fos (FLZ; O’Shea et al., 1989; Patel et al., 1996; 
Rieker and Hu, 2000; Stuhlmann-Laeisz et al., 2006) to GRK5-EE and 
GRK5. JLZ-GRK5-EE and FLZ-GRK5-EE coimmunoprecipitated after 
expression in HEK293 cells, consistent with the ability of the attached 
leucine zipper motifs to promote dimerization (Figure 5C). Of impor-
tance, immunofluorescence microcopy in HEK293 cells showed that 
leucine zipper–mediated GRK5-EE dimers (JLZ-GRK5-EE and FLZ-
GRK5-EE) were relocalized on the PM compared with cytoplasmic 
GRK5-EE (Figure 5A). Fractionation analysis of JLZ-GRK5-EE and 
FLZ-GRK5-EE also demonstrated significant increase in membrane 
that GRK5-EE is not detected in a complex in this assay due to its 
localization in the cytoplasm rather than the PM, we generated PM-
localized forms of GRK5-EE by appending a C-terminal CaaX motif 
from K-Ras. Although strongly targeted to the PM (Supplemental 
Figure S3), S- and HA-tagged forms of GRK5-EE-CaaX were greatly 
reduced in their ability to coprecipitate compared with tagged forms 
of GRK5 or GRK5-CaaX (Figure 4A). Similarly, appending an addi-
tional C-terminus rescues PM localization of GRK5-EE (described 
later in Figure 6) but does not promote coprecipitation (Supplemen-
tal Figure S4). Thus lack of PM localization does not explain the in-
ability of GRK5-EE to coprecipitate in this assay. Instead, our results 
using cross-linking followed by coprecipitation are consistent with 
GRK5 forming dimers or higher-order complexes in cells, and muta-
tion at the HDI disrupts this interaction.
In addition, we examined GRK5 complex formation using accep-
tor photobleaching fluorescence resonance energy transfer (FRET; 
Figure 4, B–D). GRK5–green fluorescent protein (GFP) and GRK5-
mCherry were coexpressed in HEK293 cells and, as expected, colo-
calized on the PM (Figure 4B). On photobleaching the GRK5-
mCherry fluorescence in a region of interest at the PM, the GRK5-GFP 
fluorescence was enhanced, indicating close association of GRK5-
GFP and GRK5-mCherry (Figure 4, C and D). A positive control in 
which GFP and the red fluorescent protein DsRed2 are linked in a 
single fusion protein gave a strong FRET signal (Figure 4, B–D). To 
control for FRET that is simply a consequence of colocalization at 
the PM rather than a protein–protein interaction, GFP was targeted 
to the PM by virtue of fusion to the first 10 amino acids of the G 
FIGURE 4: HDI-mediated self association of GRK5. (A) Pairs of S and HA epitope–tagged forms of GRK5, GRK5-EE, 
GRK5-CaaX, or GRK5-EE-CaaX were transiently coexpressed in HEK293 cells as indicated. Cells were treated with the 
cell-permeable cross-linker DSP, cells were then lysed, and affinity precipitation was performed with S-agarose beads. 
The S-agarose pull down was immunoblotted with an HA antibody to detect coprecipitation of the two tagged forms of 
GRK5 (top), and cell lysates were immunoblotted with HA antibody (middle) or S antibody (bottom). Immunoblots 
shown are representative from at least three experiments. The black bars indicate a 70-kDa standard. The graph shows 
quantitation (average ± SD, n = 3) of relative coprecipitation efficiency of the S- and HA-tagged forms of GRK5-EE-CaaX 
(EE-CaaX) vs. the S- and HA-tagged forms of GRK5-CaaX (wt-CaaX). Quantitation of the pull-down gel bands of 
GRK5-EE-CaaX and GRK5-CaaX (top) were normalized by the input cell lysate (middle). The asterisk indicates statistical 
significance (t test, p < 0.05) of the relative coprecipitation efficiency of GRK5-EE-CaaX vs. GRK5-CaaX. (B–D) HEK293 
cells were transfected with the indicated pairs of plasmids. As described in Materials and Methods, cells were imaged 
by confocal microscopy. Merged images of the GFP and mCherry channels are shown. Bar, 10 μm. Regions of interest as 
shown by the red rectangles in B were analyzed by acceptor photobleaching FRET. Fluorescence changes in the GFP 
channel were determined before and after acceptor photobleaching of mCherry (50-s application of 543-nm 
wavelength) in regions of interest (asterisk in B indicates the region of interest shown in C). (D) The FRET efficiency of 
GRK5-GFP + GRK5-mCherry calculated from E = (ID − IDA)/ID, where ID is the peak in the presence of the sensitized 
acceptor and IDA is the peak of donor (GFP) emission in the presence of the acceptor. The Gi2(1-10)-GFP + GRK5-
mCherry pair was used as negative and the GFP-DsRed as positive control for protein–protein interaction, respectively. 
Each bar represents mean ± SEM of FRET efficiency, using six cells with three regions of interest per cell (n = 18). 
Statistical analysis was performed using t-test comparison between groups. Asterisks (***) indicate statistical 
significance (p < 0.0001). Similar results were obtained in three experiments.
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quired for membrane binding, to the HDI-domain mutant GRK5-EE 
and testing for rescue of PM localization. GRK5-EE-CT containing 
such a tandem C-terminus localized prominently at the PM, as 
opposed to the cytoplasmic localization of GRK5-EE (Figure 6A), 
showing a striking shift to being predominantly in the membrane 
fraction upon fractionation of cell lysates (Figure 6B). These results 
are consistent with a model in which dimerization of GRK5 allows 
membrane-binding domains from two molecules of GRK5 to con-
tribute to PM localization.
partitioning compared with that of GRK5-EE (Figure 5B), suggesting 
that GRK5 dimerization is essential for its PM localization.
Tandem C-termini rescue PM localization of GRK5-EE
Our model predicts that monomeric GRK5 binds weakly to mem-
branes inside cells, but dimerization allows bivalent or multivalent 
interactions with membranes and thus strong membrane binding. 
Thus we tested this idea by appending an extra C-terminal region 
(residues 546–590), containing the amphipathic helix region re-
FIGURE 5: Leucine zipper–mediated dimerization of GRK5-EE rescues PM localization. (A) HEK293 cells were 
transiently transfected with plasmids expressing S-tagged GRK5, S-tagged GRK5-EE, and S-tagged JLZ-GRK5 together 
with HA-tagged FLZ-GRK5, or S-tagged JLZ-GRK5-EE together with HA-tagged FLZ-GRK5-EE. Immunofluorescence 
microscopy was performed using a mouse monoclonal anti-S antibody followed by Alexa 594–conjugated secondary 
antibody and a rabbit polyclonal anti-HA antibody followed by Alexa 448–conjugated secondary antibody. Nuclei were 
stained with DAPI. Images shown are representative from at least three experiments. Bar, 10 μm. (B) HEK293 cells were 
transiently transfected with the indicated constructs as described in A. Subcellular fractionation into soluble (S) and 
particulate (P) fractions was performed, and samples were immunoblotted with a mouse monoclonal anti–GRK4–6 
antibody. The black bars indicate a 70-kDa standard; the one on the left corresponds to lanes 1–4, and the one on the 
right corresponds to the remaining lanes. The graph shows quantitation (average ± SD, n ≥ 3, except n = 2 for JLZ-wt, 
JLZ-EE, FLZ-wt, and FLZ-EE) of gel bands of S and P fractions from multiple experiments. Statistical analysis was 
performed using one way analysis of variance (p < 0.05) to indicate significant difference among all the groups, followed 
by t-test comparison between any of the two groups. Asterisks indicate key statistical significance (p < 0.05) of the 
indicated S fraction vs. the EE S fraction or of the indicated P fraction vs. the EE P fraction. (C) Pairs of S and HA 
epitope–tagged forms of GRK5-EE or the S-tagged JLZ-GRK5-EE and HA-tagged FLZ-GRK5-EE pair were transiently 
coexpressed in HEK293 cells as indicated. Cells were treated with the cell-permeable cross-linker DSP, cells were then 
lysed, and affinity precipitation was performed with S-agarose beads. The S-agarose pull down was immunoblotted with 
an HA antibody to detect coprecipitation of the two tagged forms of GRK5 (top), and cell lysates were immunoblotted 
with HA antibody (middle) or S antibody (bottom). Each row is from the same immunoblot at the same film exposure; 
intervening, irrelevant lanes were simply removed. The black bars indicate a 70-kDa standard. The graph shows 
quantitation (average ± SEM, n = 3) of relative coprecipitation efficiency of the S- and HA-tagged forms of the indicated 
GRK5 mutants. Quantitation of the pull-down gel bands (top) were normalized by the input cell lysate (middle). The 
asterisk indicates statistical significance (t test, p < 0.05) of the relative coprecipitation efficiency of the S-tagged 
JLZ-GRK5-EE and HA-tagged FLZ-GRK5-EE pair vs. the S-tagged GRK5-EE and HA-tagged GRK5-EE pair.
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to mediate dimeric interactions in crystal structures of GRK6 and 1. 
Second, cross-linking coprecipitation studies and FRET show GRK5–
GRK5 complex formation in transfected cells. Third, recovery of PM 
localization of the cytoplasmic GRK5 RGS domain mutant by forced 
dimerization or by appending an additional membrane-targeting C-
terminal region provides further support for a model in which di-
merization allows multivalent membrane binding of GRK5.
RGS domain–mediated dimerization of GRK5 is supported by 
recent crystal structures of GRK6 and 1 in which an extensive surface 
area forms an HDI. The overall structure of the RGS domain and the 
dimeric surface are highly similar in GRK6 and 1, and the two GRKs 
use very similar amino acids to form the HDI. Of importance, GRK5 
is also predicted to form a similar HDI based on amino acid identity 
(Lodowski et al., 2006; Figure 3A and Supplemental Figure S1). Of 
interest, dimers of purified GRK6 or 1 could not be detected in solu-
tion (Lodowski et al., 2006; Singh et al., 2008). However, those stud-
ies used a soluble palmitoylation-deficient mutant of GRK6 and a 
soluble nonfarnesylated form of GRK1. It is possible that binding to 
membranes facilitates the formation of dimers and that dimers could 
exist inside the cell in the presence of membranes and other pro-
teins. This would suggest that dimerization of these GRKs is dy-
namic inside the cell. Indeed, we were initially unable to reproduc-
ibly coimmunoprecipitate different tagged forms of GRK5, 
suggesting that GRK5 dimers were not stable upon cell lysis, but the 
use of a cell-permeable cross-linker before cell lysis allowed us to 
capture GRK5 complexes. Of importance, mutation of M165 and 
F166 (GRK5-EE), two key amino acids in the predicted HDI of GRK5, 
disrupted complex formation in our coprecipitation assay (Figure 
4A), even when GRK5-EE was localized to the PM by virtue of a 
CaaX motif. In addition, a report showed coimmunoprecipitation of 
different tagged forms of GRK5, although mutational disruption of 
the coimmunoprecipitated complex was not tested (Chen et al., 
2011). Consistent with disruption of dimerization by our mutations 
in GRK5, another report showed that a L166K mutation in GRK1, 
mapping to the same position as M165 in GRK5, resulted in the first 
crystal structure of GRK1 as a monomer (Tesmer et al., 2012). The 
L166K mutation did not perturb the overall structure of GRK1; it only 
Decreased cellular function of GRK5-EE is rescued by forced 
PM localization
Previous work demonstrated that HDI mutations in GRK1 and GRK6 
had little or no effect on phosphorylation of rhodopsin in vitro, sug-
gesting that the HDI domain does not regulate the intrinsic kinase 
activity of GRKs (Lodowski et al., 2006; Singh et al., 2008). Thus we 
predicted that GRK5-EE would have decreased ability in cells to 
regulate GPCR function due to its decreased PM localization. To test 
this, we assayed the ability of expressed GRK5 to decrease Ca2+ 
signaling by the protease-activated receptor 1 (PAR1), an estab-
lished target of GRK5 (Tiruppathi et al., 2000). Addition of thrombin 
agonist peptide to HEK293 cells results in robust Ca2+ signaling, but 
transient or stable overexpression of GRK5 reduces the Ca2+ re-
sponse to 30–40% of that of cells transfected with empty vector 
(Figure 7, A and B). In contrast, in HEK293 cells transiently or stably 
overexpressing PM localization-deficient GRK5-EE, Ca2+ release 
upon activation of PAR1 was 70% of that of control cells (Figure 7, A 
and B). As a comparison, GRK5-4A, containing mutations of the four 
key hydrophobic residues in the C-terminal amphipathic helix 
membrane-binding region (Thiyagarajan et al., 2004), is likewise de-
ficient in inhibiting PAR1-mediated Ca2+ signaling (∼80% of control) 
compared with wt GRK5 (Figure 7A), consistent with decreased lo-
calization at the PM. When HEK293 cells were transiently transfected 
with PM-bound GRK5-EE-CT or GRK5-EE-CaaX, PAR1-mediated 
Ca2+ signaling was inhibited in a manner similar to that seen with 
GRK5 (Figure 7, C and D), showing that restoration of PM localiza-
tion can recover the decreased function of GRK5-EE.
DISCUSSION
This article demonstrates a key role for a surface of the RGS domain 
of GRK5 in regulating its PM localization. The results provide evi-
dence for a novel PM targeting mechanism in which RGS domain–
mediated dimerization is necessary for PM localization of GRK5. 
Several lines of evidence support this. First, chimeras and site-spe-
cific mutations show that disruption of select RGS-domain amino 
acids results in loss of PM localization of GRK5. Moreover, these 
amino acids map to a surface of the RGS domain that was observed 
FIGURE 6: Tandem C-termini promote PM localization of GRK5-EE. (A) Plasmids expressing GRK5-EE, S-tagged 
GRK5-CT, or S-tagged GRK5-EE-CT were transiently transfected into HEK293 cells. Immunofluorescence microscopy 
was performed using a mouse monoclonal anti–GRK4–6 antibody or the mouse monoclonal anti-S antibody as 
described in Materials and Methods. Images shown are representative from at least three experiments. Bar, 10 μm. 
(B) Plasmids expressing GRK5-EE, S-tagged GRK5-CT, or S-tagged GRK5-EE-CT were transiently transfected into 
HEK293 cells. Subcellular fractionation into soluble (S) and particulate (P) fractions was performed, and samples were 
immunoblotted with a mouse monoclonal anti–GRK4–6 antibody or the mouse monoclonal anti-S antibody. The black 
bars indicate a 70-kDa standard; the one on the left corresponds to lanes 1 and 2, and the one on the right corresponds 
to the remaining lanes. The graph shows quantitation (average ± SD, n = 3) of gel bands of S and P fractions from 
multiple experiments. Statistical analysis was performed using one-way analysis of variance (p < 0.05) to indicate 
significant difference among all the groups, followed by t-test comparison between any of the two groups. Asterisks 
indicate statistical significance (p < 0.01) of the indicated S fraction vs. the EE S fraction or of the indicated P fraction vs. 
the EE P fraction.
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disrupted the ability of GRK1 to crystallize as a dimer. A key future 
question is whether one can detect self-association of endogenous 
GRKs, specifically GRK1, 5, or 6. This a very challenging question, as 
there exists a dearth of techniques for demonstrating homodi-
merization of an endogenous nontagged protein.
In addition to suggesting that GRK5 dimerizes in the cell to pro-
mote PM localization, our results raise the possibility that lack of di-
merization of GRK4 may be responsible for our observation that 
expressed GRK4 is cytoplasmic rather than localized to the PM 
(Figures 1 and 2). Although RGS domain sequence comparisons in-
dicate that GRK2 and 3 do not have an HDI, all other GRKs were 
predicted to have a similar HDI capable of mediating dimerization 
(Lodowski et al., 2006). However, our GRK5/4 chimeras indicate im-
portant differences in the two RGS domains in terms of promoting 
PM localization, and closer inspection of the RGS sequence identi-
fies key amino acid differences that might prevent formation of a 
HDI in GRK4. Specifically, GRK6 and 1 dimerize in crystal structures 
using a central interdigitated aromatic stack and additional hydro-
phobic interactions composed of amino acids I39/I165/Y166/F527 
and L44/L166/Y167/W531, respectively, and GRK5 has a similar pre-
dicted hydrophobic core consisting of I39/M165/F166/F527. How-
ever, the amino acids at the similar positions in GRK4 are V39/S166/
Y167/S528. The presence of S166 rather than a hydrophobic isoleu-
cine, leucine, or methionine and the presence of S528 rather than 
the hydrophobic phenylalanine or tryptophan would be predicted 
to prevent the formation of an HDI in GRK4. Thus we speculate that 
the observed cytoplasmic localization of GRK4 (Figures 1 and 2) re-
flects an inability of GRK4 to dimerize, and, moreover, we predict 
that introduction of an HDI into GRK4 would promote its PM local-
ization. Initial attempts to test this idea by generating GRK4/GRK5 
chimeras failed to relocalize GRK4 to the PM. Certainly, it is easier to 
generate loss-of-function/localization than gain-of-function/localiza-
tion mutants, and the mechanism behind the localization differences 
of GRK5 and 4 remain to be understood.
One functional role for dimerization of GRK5 appears to be sim-
ply to regulate PM localization. We showed that the cytoplasmic HDI 
mutant GRK5-EE less efficiently reduced PAR1-mediated calcium 
signaling than PM-localized GRK5 wt; however, returning GRK5-EE 
to the PM by appending a CaaX motif or an additional GRK5 C-ter-
minus allowed GRK5-EE to function similarly to GRK5 wt (Figure 7). 
Consistent with this, it is worth noting that other reports have shown 
that mutation of key HDI residues in GRK1, 6, and 5 do not affect 
kinase activity and phosphorylation of GPCRs in vitro (Lodowski 
et al., 2006; Singh et al., 2008; Baameur et al., 2010). However, we 
cannot rule out that GRK5 dimerization has functional roles indepen-
dent of regulating PM localization. In this regard, Chen et al. (2011) 
proposed that dimerization of GRK5 is necessary for a novel role of 
FIGURE 7: Regulation of PAR1-mediated signaling by GRK5-EE. 
(A) HEK293 cells were either stably or transiently transfected with 
vector (V), GRK5 (wt), GRK5-EE (EE), or GRK5-4A (4A) as indicated. 
The cells were treated with 100 nM PAR1 agonist peptide. The 
change of cytoplasmic calcium concentration was measured using a 
Fura-2 calcium mobilization assay described in Materials and 
Methods. Briefly, the calcium concentration reflected by the ratio of 
emission at 340/380 nm (y-axis) was recorded over time of stimulation 
(x-axis). The peak value (the distance between the top of the peak 
and baseline) of the calcium concentration curve was calculated to 
reflect the maximal magnitude of PAR1 signaling activation for each of 
the transfected samples. (B, C) PAR1 peptide agonist–stimulated 
calcium release was measured in HEK293 cells stably expressing 
GRK5 or GRK5-EE or HEK293 cells transiently expressing GRK5, 
GRK5-EE, GRK5-CT, GRK5-EE-CT, GRK5-CaaX, or GRK5-EE-CaaX, as 
indicated. The peak value of the calcium concentration in vector 
transfected cells was normalized as arbitrary unit 1. Statistical analysis 
was performed using one-way analysis of variance (p < 0.05) to 
indicate significant difference among all the groups, followed by t-test 
comparison between any of the two groups (B and C, n = 3). 
*p < 0.05. (D) Cell lysates from a representative experiment of 
transiently transfected HEK293 cells were immunoblotted using the 
GRK4–6 antibody. The black bar indicates a 70-kDa standard.
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Jun leucine zipper (JLZ) motif (RIARLEEKVKTLKAQNSELASTANML-
REQVAQLKQKVMN) and the Fos leucine zipper (FLZ) motif (LT-
DTLQAETDQLEDEKSALQTEIANLLKEKEKLEFILAA) were amplified 
by PCR. Following an initiating methionine, each motif sequence 
was appended to the N-terminal end of GRK5 by a peptide linker 
(GGSGGGSGGGSG). Tandem C-termini constructs were generated 
by linking a GRK5 C-terminal region (amino acids 546–590) to the 
C-terminal end of full-length GRK5 following a peptide linker 
(DSAGSAG). To make GRK5 CaaX constructs, a K-Ras4B CaaX tail 
(GKKKKKKSKTKCVIM) was directly appended downstream of the S 
or HA tags of GRK5 constructs. All the constructs were cloned into 
pcDNA3.1 or pcDNA3 vector.
Plasmid transfection
For transient transfection, cells were seeded at 40–50% confluency 
in cell culture dishes overnight. Plasmids were mixed with Lipo-
fectamine 2000 reagent (Invitrogen, Grand Island, NY) at reagent-
to-DNA ratio of 3:1 according to manufacturer’s protocol. The mix-
ture was placed in the cell dishes, and the cells were incubated for 
48 h before further analysis. The stable line of GRK5-expressing 
HEK293 cells was also generated for this study. Briefly, GRK5 plas-
mids were transfected into HEK293 cells, and positive clones were 
screened in the presence of G418.
Immunofluorescence microscopy
Cells were fixed in 3.7% formaldehyde on coverslips for 15 min, 
followed by incubation in TBS solution supplemented with 1% 
Triton X-100 (TBS-Triton) and 2.5% milk for blocking for 20 min. 
Then cells were incubated with primary antibodies (mouse mono-
clonal anti-S tag [Novagen, Darmstadt, Germany], rabbit poly-
clonal anti-HA tag [Santa Cruz, Biotechnology, Dallas, TX], and 
mouse monoclonal anti-GRK4-6 [Millipore, Darmstadt, Germany]) 
at dilution of 1:1000 (for all the primary antibodies used) in TBS-
Triton solution with 2.5% milk for 1 h at room temperature, fol-
lowed by five washes with TBS-Triton solution with 2.5% milk. 
Cells were then incubated with anti-mouse and anti-rabbit sec-
ondary antibodies preconjugated with Alexa 488 or Alexa 594 
(Invitrogen) at dilution of 1:100 (for both secondary antibodies) in 
TBS-Triton solution with 2.5% milk for 30 min at room tempera-
ture, followed by five washes with TBS-Triton solution. The nuclei 
were stained with 4′,6-diamidino-2-phenylindole (DAPI). Cover-
slips were mounted to glass slides in Prolong Gold antifade 
mounting medium (Invitrogen) overnight. Images were recorded 
with an Olympus BX-61 microscope (Olympus, Melville, NY) and 
60× planApo objective with an ORCA-ER (Hamamatsu, Bridgewa-
ter, NJ) cooled charge-coupled device camera controlled by 
SlideBook, version 4.0 (Intelligent Imaging Innovation, Denver, 
CO). Images were transferred to Photoshop (Adobe, San Jose, 
CA) for digital processing.
Quantitation of single cells was performed after deconvolution. 
Image stacks were deconvolved using a constrained iterative algo-
rithm in SlideBook, version 4.0, and images of xy-planes through 
the middle of cells were used for analysis. Quantitation of decon-
volved images of single cells was performed using the Plot Profile 
tool of ImageJ (National Institutes of Health, Bethesda, MD). The 
relative magnitude GRK5 distribution along a linear slice of the cell 
was quantitated, similar to that described previously (Thiyagarajan 
et al., 2002; Irannejad et al., 2013). The pixel intensity in eight or 
nine line scans from four or more cells for each GRK5 mutant was 
determined, the pixel intensity was normalized to 1, and then the 
average pixel intensity was plotted using Prism (GraphPad, La 
Jolla, CA).
GRK5 in actin bundling. Future studies will be needed to fully define 
the role of the HDI region of the RGS domain in GRK5 function.
We propose a refined model for the mechanisms that regulate 
PM localization of GRK5. Previous work showed that the C-terminal 
region of GRK5 was a critical determinant of PM localization, and 
our previous studies predicted that a C-terminal amphipathic helix 
was crucial (Pronin et al., 1998; Thiyagarajan et al., 2004; Jiang et al., 
2007). The C-terminal amphipathic helix, which is also present in 
GRK4 and GRK6, is proposed to bind membranes through a central 
patch of hydrophobic amino acid side chains and also by surround-
ing basic amino acids that would interact with acidic membrane lipid 
headgroups. In addition, GRK5 can interact with membranes via an 
N-terminal basic region shown to bind phosphatidylinositol 4,5-bis-
phosphate (PIP2; Pitcher et al., 1996; Chen et al., 2011). Whether 
the N-terminal PIP2-binding motif directs PM localization or modu-
lates membrane domain localization and kinase activity once GRK5 
is localized to the PM remains to be clearly defined. Nonetheless, it 
is clear that multiple regions of GRK5 can contribute to PM localiza-
tion. However, our results predict that such membrane-binding re-
gions promote only weak membrane localization of monomeric 
GRK5 inside the cell. Consequently, dimerization of GRK5 would 
allow multivalent and therefore strong membrane binding. Consis-
tent with this idea, our previous work showed that whereas the C-
terminal amphipathic helix region of GRK5 was necessary for PM 
localization, when fused to GFP it only promoted partial PM localiza-
tion, suggesting that the C-terminus is a weak membrane-targeting 
signal (Thiyagarajan et al., 2004). Following from this idea, in this 
study PM localization of cytoplasmic GRK5-EE was recovered when 
an additional C-terminus was fused to it. We propose that in the 
absence of RGS domain–mediated dimerization, the additional C-
terminus mimicked the multivalent membrane binding that would 
be promoted by GRK5 dimerization. Such dimerization-facilitated 
strong membrane localization has been observed in other proteins. 
For example, dimerization has been shown to be necessary for 
phosphatidylinositol 3-phosphate–binding FYVE domains to pro-
mote strong localization to endosomal membranes (Hayakawa et al., 
2004; Cho and Stahelin, 2005).
Taken together, previous work and our results here suggest a 
novel model in which dimerization of GRK5 is critical for PM localiza-
tion. Regulation of the ability of GRK5 to dimerize would provide a 
point of regulation of GRK5’s localization and function inside the 
cell. Moreover, the development of an inhibitor to disrupt GRK5 
self-association, and thus PM localization and function, may provide 
a way to specifically target GRK5 in disease.
MATERIALS AND METhODS
Cell culture
HEK293 cells were cultured in DMEM supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin and streptomycin. All cell lines 
were incubated in a 5% CO2 atmosphere at 37°C.
Constructs
The full-length human GRK5 in pcDNA3 construct was provided by 
Jeffrey Benovic (Thomas Jefferson University, Philadelphia, PA; 
Kunapuli and Benovic, 1993). Human GRK4α was generously pro-
vided by Richard Premont (Duke University, Durham, NC) and was 
subcloned into pcDNA3. Single or double mutations of the RGS 
domain, as well as the quadruple mutant GRK5/4RGS(165–169), 
were generated using QuikChange (Stratagene) site-directed muta-
genesis. S tag (KETAAAKFERQHMDS) or HA tag (YPYDVPDYA) 
was fused at the carboxy terminus of GRK5 constructs. To gener-
ate leucine zipper constructs, the nucleotide fragments of the 
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pEGFP(N1)-GRK5 and pmCherry(N1)-GRK5, 2) a plasmid pair of 
pEGFP(N1)-Gi2(1-10) and pmCherry(N1)-GRK5, or 3) a control plas-
mid pEGFP(N1)-DsRed2, respectively. Twenty-four hours after trans-
fection, cells were replated (3 × 105 cells/well) onto coverslips. 
Twenty-four hours after replating, cells were fixed in 3.7% formalde-
hyde in PBS for 20 min at room temperature, washed with PBS, and 
mounted onto slides. For the acceptor photobleaching FRET, a 63× 
magnification/1.4 numerical aperture oil immersion objective was 
used with the pinhole for visualization, and images were obtained 
by placing the slide onto a stage in a Zeiss LSM710 confocal micro-
scope (Carl Zeiss, Jena, Germany). Three regions of each cell were 
acceptor-photobleached. The 488-nm laser line was used for imag-
ing GFP, and the 543-nm laser line was used for the acceptor-photo-
bleaching. FRET efficiency (E) was calculated from the GFP channel 
images according to E = (ID − IDA)/ID, where ID is the peak in the 
presence of the sensitized acceptor and IDA is the peak of donor 
emission in the presence of the acceptor. Before and after the 
bleaching of mCherry, GFP images were collected to assess changes 
in donor fluorescence. To ensure similar expression levels when 
comparing the two sample sets GRK5-GFP/GRK5-mCh and 
Gi(1-10)-GFP/GRK5-mCh, cells for analysis were used for which 
1) GFP and mCh intensities were similar between the two sample 
sets and 2) the mCh/GFP intensity ratios were similar between the 
two sample sets.
Statistical analysis
All the statistical analyses were performed using Prism. p < 0.05 was 
considered statistically significant.
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